A class action brought against Hemispherx Biopharma by its shareholders has survived a motion to dismiss in federal court in Philadelphia.
http://ift.tt/MkE943
http://ift.tt/MkE943
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment